On August 6 last year, atomic bomb survivors held their annual commemorative lantern-floating ceremony at the Hiroshima Peace Memorial Park in Japan. Two months later, their group, Nihon Hidankyo, won ...
IN8bio ( (INAB)) has issued an announcement. On December 18, 2025, IN8bio, Inc. entered into a securities purchase agreement for a private placement of common stock and pre-funded warrants in two ...
LA JOLLA, CA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell ...
The shares of Biocon fell more than 6 percent on December 4 as the pharma company is set to consider investment into subsidiary Biocon Biologics through purchase of shares from existing shareholders ...
AVONDALE, Pa., Dec. 1, 2025 /CNW/ -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy ...
ABL Bio said on the 12th that it signed a technology transfer and joint research and development agreement with U.S.-based Eli Lilly for the "Grabody-B" platform, a technology that penetrates the ...
Australian agtech company Number 8 Bio has raised A$11 million ($12.7m) in a Series A round led by Kiwi venture capital firm Icehouse Ventures. Other investors in the round included Japanese VC firm ...
The cytokine interleukin-15 (IL-15) plays a crucial role in the immune system by affecting the development, maintenance, and function of key immune cells—NK and CD8+ killer T cells—that are involved ...
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune ...
Bio-tar, once seen as a toxic waste, can be transformed into bio-carbon with applications in clean energy and environmental protection. This innovation could reduce emissions, create profits, and ...
In trading on Friday, shares of Bio-Rad Laboratories Inc (Symbol: BIO) crossed above their 200 day moving average of $286.23, changing hands as high as $290.15 per share. Bio-Rad Laboratories Inc ...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced the collection of new data that further reinforces the security and performance of its Intelligent Fingerprinting Drug Screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results